Who owns Zai Lab Ltd?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ZLAB from SEC Form 13F filings across 102 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 102 institutions disclosed 46.4M shares of Zai Lab Ltd worth $1.22B — about 41.3% of shares outstanding; the largest disclosed holder is RTW INVESTMENTS, LP. Source: SEC Form 13F filings, parsed by EvidInvest.
102
13F holders
$1.22B
value, 2026 filers
41.3%
of shares outstanding (46.4M sh)
20
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of ZLAB's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | RTW INVESTMENTS, LP | 10.4M | $272.6M | 2.7% | 9.2% | +57.5% |
| 2 | TCG Crossover Management, LLC | 6.2M | $164.1M | 4.6% | 5.5% | +1.5% |
| 3 | Woodline Partners LP | 5.3M | $139.6M | 0.4% | 4.7% | +140.1% |
| 4 | RA CAPITAL MANAGEMENT, L.P. | 2.8M | $74.2M | 0.7% | 2.5% | -51.0% |
| 5 | GOLDMAN SACHS GROUP INC | 1.9M | $50.4M | 0.0% | 1.7% | -17.4% |
| 6 | Frazier Life Sciences Management, L.P. | 1.9M | $50.1M | 1.2% | 1.7% | 0.0% |
| 7 | TWO SIGMA INVESTMENTS, LP | 1.8M | $47.6M | 0.0% | 1.6% | +39.2% |
| 8 | BAMCO INC /NY/ | 1.6M | $41.7M | 0.1% | 1.4% | -2.5% |
| 9 | Soleus Capital Management, L.P.NEW | 1.5M | $40.6M | 1.4% | 1.4% | new |
| 10 | CITADEL ADVISORS LLC | 1.3M | $34.0M | 0.0% | 1.1% | +0.4% |
| 11 | FMR LLC | 1.1M | $28.2M | 0.0% | 1% | -62.0% |
| 12 | Spruce Street Capital LP | 1.0M | $27.5M | 4.4% | 0.9% | +273.4% |
| 13 | TORONTO DOMINION BANKNEW | 994,410 | $26.2M | 0.0% | 0.9% | new |
| 14 | Rock Springs Capital Management LP | 791,307 | $20.8M | 1.1% | 0.7% | -2.9% |
| 15 | BlackRock, Inc. | 777,483 | $20.5M | 0.0% | 0.7% | +17.0% |
| 16 | Patient Square Capital LPNEW | 591,510 | $15.6M | 2.5% | 0.5% | new |
| 17 | C WorldWide Group Holding A/S | 510,000 | $13.4M | 0.3% | 0.5% | 0.0% |
| 18 | D. E. Shaw & Co., Inc. | 504,043 | $13.3M | 0.0% | 0.4% | +257.1% |
| 19 | B Group, Inc. | 450,646 | $11.9M | 7.3% | 0.4% | 0.0% |
| 20 | JANE STREET GROUP, LLC | 437,530 | $11.5M | 0.0% | 0.4% | -8.2% |
| 21 | SUPERSTRING CAPITAL MANAGEMENT LP | 362,671 | $9.6M | 4.8% | 0.3% | +132.8% |
| 22 | Nantahala Capital Management, LLC | 330,000 | $8.7M | 0.3% | 0.3% | +65.0% |
| 23 | NAN FUNG TRINITY (HK) LTD | 293,966 | $7.7M | 0.7% | 0.3% | -15.2% |
| 24 | Hennion & Walsh Asset Management, Inc. | 263,097 | $6.9M | 0.2% | 0.2% | +14.2% |
| 25 | NEXTBio Capital Management LP | 238,362 | $6.3M | 2.7% | 0.2% | +30.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.